KRAS and neoplasm: However, this did not lead to enhanced tumor susceptibility in vivo, as a result we wanted to further investigate tumorigenesis in the LSL-Kras, Rb1∆L/∆L mice more closely by quantifying the number of lesions that develop in response to Kras activation.